skip to main content

    Updated Visitor Guidelines

 

MENU

 

International biotech startup to develop U-M anti-cancer compounds goes public

Ascentage Pharma Group International, co-founded by U-M faculty member Shaomeng Wang, Ph.D., is now trading on Hong Kong’s stock exchange after an initial public offering. The company develops new therapies for cancer and other diseases.

Using Advanced Imagery to Detect Cancer Early

Rogel Cancer Center member and researcher Thomas Wang, M.D., Ph.D. is part of an interdepartmental team awarded by the National Institute for Health to study ways to improve endoscopy.

University of Michigan Awarded $3.8 Million for Cancer Research

This 'Cancer Moonshot' research grant has been awarded to the University of Michigan's Dental School. Dr. Yu Leo Lei, a Rogel Cancer Center member, will lead researchers from U-M, other universities on new cancer prevention therapies.

Rogel Cancer Center Researcher Named Member of the National Academy of Medicine

University of Michigan Rogel Cancer Center member Gabriel Nuñez, M.D., is among the new members of the National Academy of Medicine of the National Academies, one of the highest honors in the fields of health and medicine. (The institute was formerly called the Institute of Medicine.)

Cancer Patients Want to Speak Directly with Pathologists

Some of the most important players on a cancer patient’s health care team are people they typically never meet or interact with -- the pathologists.

Patient cancer cells reliably grow on new 3D scaffold, showing promise for precision medicine

At present, some patients have samples of their cancer cells grown in mice for drug testing and analysis, but the cancer cells don’t always grow and the process takes months.

Screening for lung cancer based on risk could save lives

Changing the way individuals are selected to be screened for lung cancer could prevent 14% of lung cancer deaths per year.

Pages